Estimated savings from international reference pricing for prescription drugs

JAMA

10 September 2021 - High prescription drug prices have important implications for health care spending, patient financial burden, and adherence.

Prices for brand name drugs in particular are higher in the US compared with other high-income countries, most of which regulate drug prices.

We estimated what 2020 national US savings would have been at HR 3 maximum international prices rather than US manufacturer and net prices for insulins and 50 top brand name drugs by sales.

Read JAMA article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Comparison